Skip to main content

Monoclonal Antibodies

  • Protocol
Molecular Biomethods Handbook

Part of the book series: Springer Protocols Handbooks ((SPH))

  • 1515 Accesses

Abstract

Like all great discoveries, the procedure developed by George Kohler and Cesar Milstein for immortalizing antibody producing B-lymphocytes (1) is essentially simple, namely, mix B-lymphocytes from the spleen of an immunized rodent with a continuously proliferating B-lymphoma cell line, then induce their membranes to fuse to give a single antibody-secreting cell (hybridoma) that will proliferate indefinitely Importantly, each hybndoma will secrete antibodies with a specificity for only one antigenic epitope, I e., the antibodies are monoclonal It is this property, together with the ability to produce unlimited amounts of antibody, that has revolutionized the use of antibodies in many areas of biological and medical research, and has found important applications not only in clinical diagnosis and therapy, but also for large-scale purification of biological materials Indeed, monoclonal antibodies (MAbs) are essential tools for the cell and molecular biologist and their use has unlocked the doors behind which the function of many proteins and other cellular molecules would have lain hidden

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kohler, G and Milstein, C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity Nature (London) 256, 495–497

    Article  CAS  Google Scholar 

  2. Galfré, G and Milstein, C (1981) Preparation of monoclonal antibodies: strategies and procedures, in Methods in Enzymology, vol 73, Immunochemical Techniques (Langone, J J. and Van Vunakis, H, eds), Academic, New York, pp 3–46

    Google Scholar 

  3. Bazin, H (1982) Production of rat monoclonal antibodies with the LOU rat non-secreting IR983F myeloma cell line, in Protides of the Biologcal Fluids, 29th Colloquium (Peeters, H, ed), Pergamon, New York, pp 615–618

    Google Scholar 

  4. Edwards, P A W, Smith, C M, Neville, A M, and O’Hare, M J (1982) A humanhuman hybridoma system based on a fast-growing mutant of the ARH-77 plasma cell leukaemia-derived line Eur J Immunol 12, 641–648

    Article  PubMed  CAS  Google Scholar 

  5. Anderson, D V, Tucker, E M, Powell, J R, and Porter, P (1987) Bovine monoclonal antibodies to the FS (K99) pilus antigen of E coh produced by munne/bovine hybridomas Vet Immunol Immunopathol 15, 223–237

    Article  PubMed  CAS  Google Scholar 

  6. Flynn, J N, Harkiss, G D, and Hopkins, J (1989) Generation of a sheep × mouse heterohybndoma cell line (1C6 3a6T 1D7) and evaluation of its use in the production of ovine monoclonal antibodies J Immunol Meth 121, 237–246

    Article  CAS  Google Scholar 

  7. Richards, C M, Aucken, H A, Tucker, E M, Hannant, D, Mumford, J A, and Powell, J R (1992) The production of equine monoclonal antibodies by horse—mouse heterohybndomas Vet Immunol Immunopathol 33, 129–143

    Article  PubMed  CAS  Google Scholar 

  8. Spieker-Polet, H, Sethupathi, P, Yam, P-C, and Knight, K L (1995) Rabbit monoclonal antibodies generating a fusion partner to produce rabbit—rabbit hybndomas Proc Natl Acad Sci USA 92, 9348–9352

    Article  PubMed  CAS  Google Scholar 

  9. Dean, C J (1984) Preparation and characterization of monoclonal antibodies to proteins and other cellular components, in Methods in Molecular Biology, vol 32 Basic Protein and Peptide Protocols (Walker, J M, ed), Humana, Totowa, NJ, pp 361–379

    Google Scholar 

  10. Gullick, W J (1984) Production of antisera to synthetic peptides, in Methods in Molecular Biology, vol 32 Basic Protein and Peptide Protocols (Walker, J M, ed), Humana, Totowa, NJ, pp 389–399

    Google Scholar 

  11. Taylor-Papadimitnou, J, Stewart, L, Burchell, J, and Beverley, P (1993) The polymorphic epithelial mucin as a target for immunotherapy Ann NY Acad Sci 690, 69–79

    Article  Google Scholar 

  12. Dean, C J, Styles, J M, Gyure, L A, Peppard, J, Hobbs, S M, Jackson, E, and Hall, J G (1984) The production of hybndomas from the gut-associated lymphoid tissue of tumour-bearing rats I Mesenteric nodes as a source of IgG producing cells Clin Exp Immunol 57, 358–364

    PubMed  CAS  Google Scholar 

  13. Harlow, E and Lane, D P (1988) Antibodies, A Laboratory Manual Cold Spring Harbor Laboratory, Cold Spring Harbor, NY

    Google Scholar 

  14. Modjtahedi, H, Styles, J M, and Dean, C J (1993) The human EGF receptor as a target for cancer therapy six new rat antibodies against the receptor on the breast carcinoma MDA-MB 468 Br J Cancer 67, 247–253

    Article  PubMed  CAS  Google Scholar 

  15. Styles, J M, Harrison, S, Gusterson, B A, and Dean, C J (1990) Rat monoclonal antibodies to the extracellular domain of the product of the c-erbB-2 proto-oncogene Int J Cancer 45, 320–324

    Article  PubMed  CAS  Google Scholar 

  16. Modjtahedi, H, Eccles, S, Box, G, Styles, J, and Dean, C (1993) Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block gowth factor—receptor interaction Br J Cancer 67, 254–261

    Article  PubMed  CAS  Google Scholar 

  17. Modjtahedi, H, Hickish, T, Nicolson, M, Moore, J, Styles, J, Eccles, S, Jackson, E, Salter, J, Sloane, J, Spencer, L, Priest, K, Smith, I, Dean, C, and Gore, M (1996) Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer Br J Cancer 73, 228–235

    Article  PubMed  CAS  Google Scholar 

  18. Eccles, S A, Court, W J, Box, G A, Dean, C J, Melton, R J, and Springer, C J (1994) Regression of established breast carcinoma xenografts with antibody directed enzyme prodrug therapy (ADEPT) against c-erbB2 p 185 Cancer Res 54, 5171–5177

    PubMed  CAS  Google Scholar 

  19. Modjtahedi, H and Dean, C (1994) The receptor for EGF and its ligands expression, prognostic value and target for therapy in cancer (review) Int J Cancer 4, 277–296

    CAS  Google Scholar 

  20. Hynes, N E and Stern, D F (1994) The biology of erbB-2/neu/HER-2 and its role in cancer Biochim Biophys Acta 1198, 165–184

    PubMed  Google Scholar 

  21. Bernaid, A (1984) Leukocyte Typing Human Leucocyte Differentiation Antigens Detected by Monoclonal Antibodies Specification, Classification, Nomenclature Spnnger-Verlag, Berlin

    Google Scholar 

  22. Barclay, A N, Brown, M H, Law, A, McKnight, A J, Tomlenson, M, Anton vander Mewe, P (1997) The Leucocyte Antigen Facts Book Academic, London, UK

    Google Scholar 

  23. Rock, K L (1996) A new foreign policy MHC class I molecules monitor the outside world Immunol Today 17, 131–137

    Article  PubMed  CAS  Google Scholar 

  24. Goldstein, G, Schindler, J, Tsai, H, et al (1985) A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants N Engl J Med 313, 337–342

    Article  Google Scholar 

  25. Waldmann, H and Cobbold, S (1993) The use of monoclonal antibodies to achieve lmmunological tolerance Immunol Today 14, 247–251

    Article  PubMed  CAS  Google Scholar 

  26. Harris, W J and Cunnngham, C (1995) Antibody Therapeutics R G Landes, Austin, TX

    Google Scholar 

  27. Press, O W, Eary, J F, Appelbaum, F R, Martin, P J, Badger, C C, Nelp, W B, Glenn, S, Butchko, G, Fisher, D, Porter, B, Mathews, D C, Fisher, L D., and Bernstein, I D (1993) Radiolabelled antibody therapy of B cell lymphoma with autologous bone marrow support N EnglJ Med 329, 1219–1224

    Article  CAS  Google Scholar 

  28. Hird, V, Maraveyas, A, Snook, D, Dhokia, B, Soutter, W P, Meares, C, Stewart, J, Mason, P, Lambert, H, and Epenetos, A (1993) Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody Br J Cancer 68, 403–406

    Article  PubMed  CAS  Google Scholar 

  29. Reithmuller, G, Schneider-Gadicke, E, Schlimok, G, Schmiegel, W, Raab, R, Pichlmair, H, Hirche, H, Pichlmayr, R, Buggisch, P, Witte, J, and the German Cancer Aid 17-1A Study Group (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes’ C colorectal carcinoma Lancet 343, 1177–1183

    Article  Google Scholar 

  30. Jones, P T, Dear, P H, Foote, J, Neuberger, M S, and Winter, G (1986) Replacing the complementarity determining regions in a human antibody with those from a mouse Nature 321, 522–525

    Article  PubMed  CAS  Google Scholar 

  31. Winter, G, Griffiths, A D, Hawkins R E, et al (1994) Making antibodies by phage display technology Ann Rev Immunol 12, 433–455

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Humana Press Inc , Totowa, NJ.

About this protocol

Cite this protocol

Dean, C., Modjtahedi, H. (1998). Monoclonal Antibodies. In: Rapley, R., Walker, J.M. (eds) Molecular Biomethods Handbook. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1007/978-1-59259-642-3_44

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-642-3_44

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-501-0

  • Online ISBN: 978-1-59259-642-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics